BlackRock Advisors’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-85,336
Closed -$2.93M 3742
2014
Q4
$2.93M Sell
85,336
-10,315
-11% -$336K ﹤0.01% 1088
2014
Q3
$2.85M Buy
95,651
+66,633
+230% +$1.41M ﹤0.01% 1087
2014
Q2
$582K Sell
29,018
-4,272
-13% -$98K ﹤0.01% 1909
2014
Q1
$905K Buy
33,290
+1,339
+4% +$35.5K ﹤0.01% 1607
2013
Q4
$662K Sell
31,951
-87,794
-73% -$1.66M ﹤0.01% 1820
2013
Q3
$2.18M Sell
119,745
-198
-0.2% -$3.58K ﹤0.01% 1145
2013
Q2
$2M Buy
+119,943
New +$1.92M ﹤0.01% 1135

Other funds holding AUXL

BlackRock Advisors's AUXL Position: Q1 2015 in Review

BlackRock Advisors sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q1 2015, closing a stake of 85,336 shares — an estimated $2.93M sold.

BlackRock Advisors first reported a position in AUXL in Q2 2013 and held it in 7 quarters. The position peaked at $2.93M in Q4 2014. 1 fund tracked by Wall St. Rank holds AUXL as of Q1 2015.

  • BlackRock Advisors reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • BlackRock Advisors sold 85,336 AUXILIUM PHARAMCEUTICALS INC shares in Q1 2015, an estimated $2.93M.
  • BlackRock Advisors first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • BlackRock Advisors's AUXILIUM PHARAMCEUTICALS INC position peaked at $2.93M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q1 2015.

Based on BlackRock Advisors's 13F filing for Q1 2015, filed 13 May 2015.